Amyloid β and Alzheimer disease therapeutics: the devil may be in the details
Alzheimer disease (AD) is characterized by the progressive accumulation of amyloid β protein (Aβ) in areas of the brain serving cognitive functions such as memory and language. The first of two separate reports (see the related articles beginning on pages 415 and 440) reveals that intrinsic T cell r...
שמור ב:
| הוצא לאור ב: | J Clin Invest |
|---|---|
| Principais autores: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Clinical Investigation
2003
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166307/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12897198/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI19420 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|